InvestorsHub Logo
Followers 64
Posts 6479
Boards Moderated 0
Alias Born 03/17/2017

Re: biosectinvestor post# 400165

Tuesday, 09/07/2021 11:00:58 AM

Tuesday, September 07, 2021 11:00:58 AM

Post# of 723692

Dr. Duffy commented, "My years at Merck, from inception of the Keytruda programs, have been exciting and invaluable. As I look forward now to the next wave of advances in immune therapies for cancer, I am excited about the potential of NW Bio's DCVax technologies to deliver new breakthroughs for patients. I hope to build on my experience in immuno-oncology and my network of relationships in the field to help NW Bio achieve this potential."



Duffy said he was helping NWBO to achieve its potential. In my view that is not just and only browsing around and doing DD on NWBO but also to actually at that moment to help NWBO move forward. As it so happens that at that moment most needed was a required independ third party that could help with the SAP. Outside consultants could not do that.

So I do believe that was one of his jobs at NWBO

But we agree to disagree
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News